The evolution of pharma customer engagement insight
Over the last three years, customer engagement in the pharmaceutical industry has evolved significantly. Despite the improvement in screen-to-screen (S2S) interactions since 2020, face-to-face (F2F) operations are still on the agenda for many pharma companies. To fully realize the potential of a fit-for-purpose engagement model, the following points should be considered:
- A blended engagement model
- Emotive, patient-centric selling
- Referencing previous HCP interactions
- Cross-functional account management
Putting this strategy into practice, a tailored engagement model can be made to achieve the best-selling outcome.
In the full article from STEM, an Inizio Advisory company, the evolution to a more integrated, hybrid and patient-centric engagement model is explored in more detail.
https://www.stemhealthcare.com/insights/the-evolution-of-pharma-customer-engagement/
Jump to a slide with the slide dots.
Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025
Inizio experts at ObesityWeek® 2025 discuss how new science, and cross-sector collaboration are reshaping the future of obesity care.
Read moreESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences.
Read moreChange management: Thinking beyond the platform
When organizations think about adopting AI, they often focus first on the platform, its features, its outputs, and its integration points.
Read more